A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2026, filed Jul 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JL SEC filings page.
J-Long Group Limited (JL) reported $42.2M in revenue for fiscal year 2026, up 8.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).
FY2026 combined stronger gross economics with weaker cash conversion, as inventory growth and higher overhead absorbed much of the improvement.
Gross margin widened from28.8% to34.0% while cost of revenue was nearly unchanged; the improvement reflects better production economics rather than volume alone. Operating cash flow fell46.0% even as net income rose6.6% ; that divergence means reported earnings stayed positive while cash conversion weakened.
Operating margin improved
Working capital absorbed cash: inventory rose
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of J-Long Group Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. J-Long Group Limited scores 49/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. J-Long Group Limited scores 83/100 on it among other operating companies.
J-Long Group Limited carried $0.69 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2026. With no long-term debt figure for fiscal year 2026, J-Long Group Limited is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 43/100 among other operating companies measured the same way.
J-Long Group Limited held $2.84 of current assets for every $1 of current liabilities at the end of fiscal year 2026, a current ratio of 2.84. Liquidity ranks operating companies on that ratio, and J-Long Group Limited scores 76/100 among other operating companies.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. J-Long Group Limited scores 57/100 on it among other operating companies.
Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. J-Long Group Limited scores 64/100 on it among other operating companies.
J-Long Group Limited scores 3.75, well above the 2.99 safe threshold. The largest contribution to the score comes from revenue of $42.2M against total assets of $28.0M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
J-Long Group Limited passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, J-Long Group Limited generates $1.41 in operating cash flow ($3.9M OCF vs $2.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
J-Long Group Limited earns $197.84 in operating income for every $1 of interest expense ($3.0M vs $15K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
J-Long Group Limited generated $42.2M in revenue in fiscal year 2026. This represents an increase of 8.1% from the prior year.
J-Long Group Limited's EBITDA was $3.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 27.4% from the prior year.
J-Long Group Limited reported $2.8M in net income in fiscal year 2026. This represents an increase of 6.6% from the prior year.
J-Long Group Limited earned $0.75 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 6.3% from the prior year.
Cash & Balance Sheet
J-Long Group Limited generated $3.2M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 48.3% from the prior year.
J-Long Group Limited held $14.7M in cash as of fiscal year 2026; no long-term debt figure is on record for that period.
Not reported for fiscal year 2026.
Margins & Returns
J-Long Group Limited's gross margin was 34.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 5.1 percentage points from the prior year.
J-Long Group Limited's operating margin was 7.0% in fiscal year 2026, reflecting core business profitability. This is up 0.9 percentage points from the prior year.
J-Long Group Limited's net profit margin was 6.6% in fiscal year 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the prior year.
J-Long Group Limited's ROE was 17.0% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the prior year.
Capital Allocation
J-Long Group Limited spent $1.1M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding.
J-Long Group Limited invested $694K in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 32.1% from the prior year.
Not reported for fiscal year 2026.
JL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Revenue | $42.2M+8.1% | $39.1M+37.7% | $28.4M-25.9% | $38.3M0.0% | $38.3M |
| Cost of Revenue | $27.9M+0.2% | $27.8M+28.9% | $21.6M-23.6% | $28.3M-4.0% | $29.4M |
| Gross Profit | $14.3M+27.4% | $11.3M+65.6% | $6.8M-32.3% | $10.0M+13.4% | $8.9M |
| SG&A Expenses | $4.4M+33.5% | $3.3M-48.3% | $6.4M+68.6% | $3.8M+14.4% | $3.3M |
| Operating Income | $3.0M+23.3% | $2.4M+530.6% | $380K-93.9% | $6.2M+12.7% | $5.5M |
| EBITDA | $3.3M+27.4% | $2.6M+396.1% | $528K-91.8% | $6.4M+11.7% | $5.7M |
| Interest Expense | $15K+2865.1% | $504-99.7% | $146K+7.6% | $136K | N/A |
| Income Tax | $792K+20.4% | $658K+418.4% | $127K-88.4% | $1.1M+25.3% | $876K |
| Net Income | $2.8M+6.6% | $2.6M+230.9% | $784K-88.2% | $6.7M+48.5% | $4.5M |
| EPS (Basic) | $0.75-6.3% | $0.80+207.7% | $0.26-88.4% | $2.24+49.3% | $1.50 |
| EPS (Diluted) | $0.75-6.3% | $0.80+207.7% | $0.26-88.4% | $2.24+49.3% | $1.50 |
| Diluted Shares (Avg) | 4M+12.6% | 3M+7.6% | 3M+0.8% | 3M0.0% | 3M |
Not reported in any period shown, so not listed: R&D Expenses.
JL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY24Filing | FY23Filing | FY2220-F |
|---|---|---|---|---|---|
| Total Assets | $28.0M+19.3% | $23.5M+38.8% | $16.9M-18.0% | $20.6M | N/A |
| Current Assets | $22.9M+20.8% | $19.0M+32.9% | $14.3M-14.6% | $16.7M | N/A |
| Cash & Equivalents | $14.7M+38.1% | $10.7M+156.4% | $4.2M-30.2% | $6.0M-19.1% | $7.4M |
| Short-Term Investments | $0-100.0% | $2K-2.4% | $2K-99.1% | $243Kn/m | $0 |
| Inventory | $4.3M+39.5% | $3.1M-31.1% | $4.4M-23.1% | $5.8M | N/A |
| Accounts Receivable | $2.5M-20.5% | $3.1M+32.1% | $2.3M+12.6% | $2.1M | N/A |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0 |
| Total Liabilities | $11.2M+33.7% | $8.4M+25.1% | $6.7M-27.4% | $9.3M | N/A |
| Current Liabilities | $8.1M+13.7% | $7.1M+32.7% | $5.3M-25.4% | $7.2M | N/A |
| Non-Current Liabilities | $3.2M+140.8% | $1.3M-4.3% | $1.4M-34.3% | $2.1M | N/A |
| Total Equity | $16.3M+11.3% | $14.6M+43.9% | $10.2M-10.4% | $11.3M+60.7% | $7.1M |
| Retained Earnings | $11.2M+32.7% | $8.5M+44.1% | $5.9M-47.0% | $11.1M | N/A |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
JL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Operating Cash Flow | $3.9M-46.0% | $7.2Mn/m | -$1.5M-176.6% | $2.0M-65.4% | $5.7M |
| Depreciation & Amortization | $381K+72.1% | $221K+49.8% | $148K-12.7% | $169K-16.5% | $203K |
| Stock-Based Compensation | $1.2M+89.7% | $655K | N/A | N/A | N/A |
| Capital Expenditures | $694K-32.1% | $1.0M+414.1% | $199K+297.7% | $50K-40.1% | $83K |
| Free Cash Flow | $3.2M-48.3% | $6.2Mn/m | -$1.7M-189.0% | $1.9M-65.8% | $5.6M |
| Investing Cash Flow | -$679Kn/m | -$1.0M-6008894.1% | $17-100.0% | $2.1Mn/m | -$83K |
| Financing Cash Flow | $786Kn/m | -$670K-195.4% | $702Kn/m | -$5.4Mn/m | -$2.2M |
| Dividends Paid | N/A | $400K-76.1% | $1.7M | N/A | N/A |
| Share Buybacks | $1.1M | N/A | N/A | N/A | N/A |
JL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2620-F | FY2520-F | FY2420-F | FY2320-F | FY2220-F |
|---|---|---|---|---|---|
| Gross Margin | 34.0%+5.1pp | 28.8%+4.9pp | 23.9%-2.3pp | 26.2%+3.1pp | 23.1% |
| Operating Margin | 7.0%+0.9pp | 6.1%+4.8pp | 1.3%-14.9pp | 16.3%+1.8pp | 14.4% |
| Net Margin | 6.6%-0.1pp | 6.6%+3.9pp | 2.8%-14.6pp | 17.4%+5.7pp | 11.7% |
| Return on Equity | 17.0%-0.7pp | 17.7%+10.0pp | 7.7%-51.0pp | 58.7%-4.8pp | 63.5% |
| Return on Assets | 9.9%-1.2pp | 11.1%+6.4pp | 4.6%-27.7pp | 32.3% | N/A |
| Current Ratio | 2.84+0.2x | 2.680.0x | 2.67+0.3x | 2.34 | N/A |
| Liabilities-to-Equity | 0.69+0.1x | 0.57-0.1x | 0.66-0.2x | 0.82 | N/A |
| Asset Turnover | 1.51-0.2x | 1.670.0x | 1.68-0.2x | 1.86 | N/A |
| FCF Margin | 7.6%-8.3pp | 15.9%+21.9pp | -6.0%-11.0pp | 5.0%-9.6pp | 14.6% |
Not reported in any period shown, so not listed: Debt-to-Equity.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| J-Long Group Limited JL | FY2026 | $42.2M | $2.8M | 6.6% | $13.0M | 62/100 |
| Neo-Concept International Group Holdings Limited NCI | FY2025 | $17.6M | $43K | 0.2% | $4.3M | 48/100 |
| Children's Place, Inc. PLCE | FY2025 | $1.2B | N/A | N/A | $6.3M | 23/100 |
| Xcel Brands Inc. XELB | FY2025 | $4.9M | -$17.5M | N/A | $2.6M | 18/100 |
| JX Luxventure Limited JXG | FY2025 | $82.9M | -$11.0M | -13.3% | $245.1M | 67/100 |
| Superior Group of Companies, Inc. SGC | FY2025 | $566.2M | $7.0M | 1.2% | $220.8M | 48/100 |
Where J-Long Group Limited Ranks
Frequently Asked Questions
J-Long Group Limited (JL) reported $42.2M in total revenue for fiscal year 2026. This represents a 8.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
J-Long Group Limited (JL) revenue grew by 8.1% year-over-year, from $39.1M to $42.2M in fiscal year 2026.
Yes, J-Long Group Limited (JL) reported a net income of $2.8M in fiscal year 2026, with a net profit margin of 6.6%.
J-Long Group Limited (JL) had EBITDA of $3.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
J-Long Group Limited (JL) had a gross margin of 34.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
J-Long Group Limited (JL) had an operating margin of 7.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
J-Long Group Limited (JL) had a net profit margin of 6.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
J-Long Group Limited (JL) has a return on equity of 17.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
J-Long Group Limited (JL) generated $3.2M in free cash flow during fiscal year 2026. This represents a -48.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
J-Long Group Limited (JL) generated $3.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
J-Long Group Limited (JL) had $28.0M in total assets as of fiscal year 2026, including both current and long-term assets.
J-Long Group Limited (JL) invested $694K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
J-Long Group Limited (JL) had a current ratio of 2.84 as of fiscal year 2026, which is generally considered healthy.
J-Long Group Limited (JL) had a liabilities-to-equity ratio of 0.69 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.
J-Long Group Limited (JL) had a return on assets of 9.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
J-Long Group Limited (JL) trades at 4.7x earnings, its market capitalization divided by $2.8M net income, FY2026. The market capitalization is $13.0M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
J-Long Group Limited (JL) trades at 0.3x sales, its market capitalization divided by $42.2M revenue, FY2026. The market capitalization is $13.0M as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
J-Long Group Limited (JL) has an Altman Z-Score of 3.75, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
J-Long Group Limited (JL) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
J-Long Group Limited (JL) has an earnings quality ratio of 1.41x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
J-Long Group Limited (JL) has an interest coverage ratio of 197.84x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
J-Long Group Limited (JL) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.